Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | — | — |
Fever of 103 fahrenheit; Loss of appetite; Dizziness; Headache; Back pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included cerebral palsy (The patient had a medical history). On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced fever (Verbatim: Fever of 103 fahrenheit), appetite lost (Verbatim: Loss of appetite), dizziness (Verbatim: Dizziness), headache (Verbatim: Headache) and back pain (Verbatim: Back pain). The outcome of the fever, appetite lost, dizziness, headache and back pain were unknown. It was unknown if the reporter considered the fever, appetite lost, dizziness, headache and back pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the fever, appetite lost, dizziness, headache and back pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JAN-2025 and 30-JAN-2025 The patient experienced Fever of 103 fahrenheit, back pain, headache, dizziness, and loss of appetite after receiving the dose of Bexsero. The reporter did not consent to follow-up.
Medical History/Concurrent Conditions: Cerebral palsy (The patient had a medical history)
Test Name: Body temperature; Result Unstructured Data: (Test Result:103,Unit:degree F,Normal Low:,Normal High:)